Peptron recorded downward static volatility interruption (VI) triggers on both NexTrade (NXT) and the Korea Exchange (KRX) on the morning of the 8th.

Regarding the conclusion of its joint research and technical evaluation with Eli Lilly, the company stated that "the contractual procedures were completed normally" and that it is inappropriate to conclude this as a failure to secure a follow-up commercialization contract.

Static VI triggered first on NXT before market open, then on KRX right after opening

On NexTrade, a static VI was triggered at 8 a.m. that day. The trigger price was 97,000 won and the reference price was 130,600 won, marking a deviation of minus 25.72%. The NexTrade VI was lifted at 8:02 a.m.

Subsequently, on the Korea Exchange, Peptron's static VI was triggered at 9:00:05 a.m. The trigger price was 99,500 won, a deviation of minus 23.81% from the static VI reference price of 130,600 won. This VI was lifted at 9:02:27 a.m. Each trigger price reflects the price at that moment and is distinct from the current price after the VI was lifted.

Joint research and technical evaluation with Lilly "completed normally per contract…agreed consideration also received"

In additional guidance regarding the technical evaluation of its SmartDepot™ platform, Peptron explained that what concluded on the 7th was the joint research and technical evaluation process under the technical evaluation contract signed with Eli Lilly.

According to the company, the two companies' joint research and technical evaluation were completed normally within the contract period, and Peptron received all the consideration stipulated in the contract. In other words, the research under the technical evaluation contract and all contractual procedures were fulfilled.

However, a follow-up commercialization contract was not signed simultaneously at the conclusion of the technical evaluation. Peptron stated that interpreting this as a 'failure' of a follow-up contract is inappropriate.

"Commercialization decision to be made by both companies after comprehensive review"…follow-up contract not confirmed

The company explained that connecting the research and evaluation results to actual product development and commercialization requires a comprehensive review of multiple factors, including commercial viability, mass producibility, marketability, and intellectual property, upon which both companies' decision-making should take place.

What was confirmed in this announcement is the normal completion of the technical evaluation contract and receipt of the agreed consideration. Whether or when a follow-up commercialization contract will be signed was not presented as a concretely confirmed matter, and the company's explanation is also difficult to interpret as a commitment to sign a contract.

Peptron stated that it will enhance the business value of the results secured through the joint research and technical evaluation, and will continue business development activities so that the SmartDepot™ platform leads to product development and commercialization outcomes. Matters concretely confirmed in the future will be announced in accordance with relevant laws and procedures.

[This article is for informational purposes based on company disclosures and VI trigger records, and does not recommend buying or selling any specific stock. VI trigger prices and deviations from reference prices may differ from real-time current prices and change rates versus the previous day's close. The follow-up contract and commercialization status are not confirmed, and investment decisions and their responsibility rest with the investor. AI assistance was used in writing this article.]